Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (556) 556
science & technology (515) 515
life sciences & biomedicine (504) 504
female (362) 362
male (356) 356
tetrahydronaphthalenes - adverse effects (323) 323
tetrahydronaphthalenes - therapeutic use (310) 310
middle aged (291) 291
tetrahydronaphthalenes - administration & dosage (239) 239
aged (234) 234
biological and medical sciences (206) 206
adult (190) 190
medical sciences (188) 188
animals (159) 159
tetrahydronaphthalenes - pharmacology (149) 149
pharmacology & pharmacy (140) 140
treatment outcome (128) 128
pharmacology. drug treatments (120) 120
thiophenes - administration & dosage (110) 110
double-blind method (108) 108
neurosciences & neurology (108) 108
dose-response relationship, drug (100) 100
thiophenes - adverse effects (100) 100
parkinson disease - drug therapy (98) 98
clinical neurology (94) 94
rotigotine (94) 94
thiophenes - therapeutic use (93) 93
dopamine agonists - administration & dosage (88) 88
dopamine agonists - adverse effects (81) 81
mibefradil (80) 80
dopamine agonists - therapeutic use (79) 79
parkinson's disease (79) 79
administration, cutaneous (77) 77
aged, 80 and over (77) 77
neurology (77) 77
tetrahydronaphthalenes - pharmacokinetics (71) 71
bexarotene (69) 69
dermatology (69) 69
abridged index medicus (67) 67
oncology (62) 62
skin neoplasms - drug therapy (55) 55
calcium channel blockers - therapeutic use (51) 51
drug therapy, combination (51) 51
benzimidazoles - therapeutic use (50) 50
rats (49) 49
anticarcinogenic agents - adverse effects (48) 48
calcium channel blockers - adverse effects (48) 48
care and treatment (48) 48
restless legs syndrome - drug therapy (48) 48
benzimidazoles - adverse effects (47) 47
mice (47) 47
anticarcinogenic agents - therapeutic use (46) 46
adolescent (45) 45
restless legs syndrome (45) 45
transdermal patch (45) 45
clinical trials (44) 44
clinical trials as topic (44) 44
dopamine agonist (44) 44
medicine & public health (44) 44
neurosciences (44) 44
transdermal medication (43) 43
administration, oral (42) 42
lymphoma, t-cell, cutaneous - drug therapy (42) 42
antineoplastic agents (41) 41
drug therapy (41) 41
retinoids (41) 41
analysis (40) 40
antineoplastic agents - adverse effects (40) 40
time factors (39) 39
young adult (39) 39
dopamine (38) 38
antineoplastic agents - therapeutic use (35) 35
anticarcinogenic agents - administration & dosage (34) 34
cardiovascular system & cardiology (34) 34
severity of illness index (34) 34
cardiovascular system (33) 33
hypertension - drug therapy (33) 33
mycosis fungoides - drug therapy (33) 33
drug administration schedule (32) 32
hematologic and hematopoietic diseases (32) 32
chemotherapy (31) 31
drug interactions (31) 31
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (31) 31
skin neoplasms - pathology (31) 31
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
blood pressure - drug effects (30) 30
research (30) 30
toxicology (30) 30
pyrrolidines - therapeutic use (29) 29
antiparkinson agents - adverse effects (28) 28
antiparkinson agents - therapeutic use (28) 28
cardiac & cardiovascular systems (28) 28
follow-up studies (28) 28
medical research (28) 28
tetrahydronaphthalenes (28) 28
general & internal medicine (27) 27
heart rate - drug effects (27) 27
medicine, general & internal (27) 27
pharmacology/toxicology (27) 27
thiophenes - pharmacokinetics (27) 27
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (637) 637
Japanese (10) 10
Spanish (7) 7
German (5) 5
Chinese (4) 4
French (4) 4
Russian (2) 2
Czech (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study
by Garcia-Ruiz, Pedro J and Martinez Castrillo, Juan Carlos and Alonso-Canovas, Araceli and Herranz Barcenas, Antonio and Vela, Lydia and Sanchez Alonso, Pilar and Mata, Marina and Olmedilla Gonzalez, Nuria and Mahillo Fernandez, Ignacio
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 08/2014, Volume 85, Issue 8, pp. 840 - 845
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Thiophenes - therapeutic use | Age Factors | Thiophenes - adverse effects | Humans | Middle Aged | Dopamine Agonists - therapeutic use | Tetrahydronaphthalenes - therapeutic use | Male | Dopamine Agonists - adverse effects | Parkinson Disease - drug therapy | Administration, Cutaneous | Tetrahydronaphthalenes - adverse effects | Antiparkinson Agents - therapeutic use | Disruptive, Impulse Control, and Conduct Disorders - psychology | Female | Parkinson Disease - complications | Administration, Oral | Parkinson Disease - psychology | Antiparkinson Agents - adverse effects | Disruptive, Impulse Control, and Conduct Disorders - chemically induced | Indoles - adverse effects | Levodopa - adverse effects | Sex Factors | Indoles - therapeutic use | Aged | Benzothiazoles - therapeutic use | Benzothiazoles - adverse effects | Complications and side effects | Care and treatment | Usage | Parkinson's disease | Dopamine | Agonists | Research | Impulsive personality | Risk factors | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Restless legs syndrome: clinical presentation diagnosis and treatment
by Wijemanne, Subhashie and Jankovic, Joseph
Sleep medicine, ISSN 1389-9457, 2015, Volume 16, Issue 6, pp. 678 - 690
Neurology | Sleep Medicine | Augmentation | Restless legs syndrome | Ropinirole | Gabapentin | Dopamine agonist | Rotigotine | Methadone | Pramipexole | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Restless Legs Syndrome - diagnosis | Thiophenes - therapeutic use | Cyclohexanecarboxylic Acids - therapeutic use | Thiophenes - adverse effects | Humans | Cyclohexanecarboxylic Acids - adverse effects | Dopamine Agonists - therapeutic use | Methadone - therapeutic use | Tetrahydronaphthalenes - therapeutic use | Analgesics, Opioid - therapeutic use | Dopamine Agonists - adverse effects | Tetrahydronaphthalenes - adverse effects | Restless Legs Syndrome - drug therapy | Restless Legs Syndrome - etiology | Analgesics, Opioid - adverse effects | Indoles - adverse effects | Amines - therapeutic use | Indoles - therapeutic use | Amines - adverse effects | Benzothiazoles - therapeutic use | Methadone - adverse effects | gamma-Aminobutyric Acid - therapeutic use | Benzothiazoles - adverse effects | gamma-Aminobutyric Acid - adverse effects | Diagnosis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs
by Torino, Francesco and Barnabei, Agnese and Paragliola, Rosamaria and Baldelli, Roberto and Appetecchia, Marialuisa and Corsello, Salvatore Maria
Thyroid (New York, N.Y.), ISSN 1050-7256, 11/2013, Volume 23, Issue 11, pp. 1345 - 1366
Reviews and Scholarly Dialog | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Interleukin-2 - metabolism | Thalidomide - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Hypothyroidism - chemically induced | Interferon-alpha - metabolism | Interleukin-2 - adverse effects | Recombinant Fusion Proteins - adverse effects | Humans | Antibodies, Monoclonal - adverse effects | Alemtuzumab | Tetrahydronaphthalenes - adverse effects | Neoplasms - drug therapy | Neoplasms - complications | Thalidomide - analogs & derivatives | Animals | Antineoplastic Agents - adverse effects | Diphtheria Toxin - adverse effects | Thyroid Hormones - metabolism | Thyroxine - metabolism | Thyroid Diseases - chemically induced | Thyroid Gland - drug effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Cardiac and noncardiac fibrotic reactions caused by ergot‐and nonergot‐derived dopamine agonists
by Andersohn, Frank and Garbe, Edeltraut
Movement disorders, ISSN 0885-3185, 01/2009, Volume 24, Issue 1, pp. 129 - 133
adverse drug reaction reporting systems | adverse effects | fibrosis | dopamine agonists | Dopamine agonists | Adverse drug reaction reporting systems | Adverse effects | Fibrosis | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Biological and medical sciences | Anticonvulsants. Antiepileptics. Antiparkinson agents | Medical sciences | Neuropharmacology | Pharmacology. Drug treatments | United States - epidemiology | Heart Valve Diseases - pathology | Thiophenes - adverse effects | Humans | Middle Aged | Male | Dopamine Agonists - adverse effects | Bromocriptine - adverse effects | Ergolines - adverse effects | Tetrahydronaphthalenes - adverse effects | Apomorphine - adverse effects | Pulmonary Fibrosis - epidemiology | Pericarditis - epidemiology | Fibrosis - epidemiology | Heart Valve Diseases - epidemiology | Pericarditis - chemically induced | Aged, 80 and over | Heart Valve Diseases - chemically induced | Female | Endomyocardial Fibrosis - chemically induced | Databases, Factual | Fibrosis - chemically induced | Endomyocardial Fibrosis - epidemiology | Pericarditis - pathology | Pleural Diseases - chemically induced | Pergolide - adverse effects | Retroperitoneal Fibrosis - epidemiology | Indoles - adverse effects | Pleural Diseases - epidemiology | Pulmonary Fibrosis - chemically induced | Aged | Retroperitoneal Fibrosis - chemically induced | Benzothiazoles - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion
by Assaf, C and Bagot, M and Dummer, R and Duvic, M and Gniadecki, R and Knobler, R and Ranki, A and Schwandt, P and Whittaker, S
08/2006, Volume 155, Issue 2, 6
bexarotene | rexinoid | hypothyroidism | cutaneous T-cell lymphoma | hypertriglyceridaemia | cutaneous T‐cell lymphoma | Bexarotene | Hypothyroidism | Hypertriglyceridaemia | Rexinoid | Cutaneous T-cell lymphoma | Life Sciences & Biomedicine | Dermatology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Metabolic diseases | Medical sciences | Disorders of blood lipids. Hyperlipoproteinemia | Hypothyroidism - chemically induced | Skin Neoplasms - drug therapy | Humans | Tetrahydronaphthalenes - therapeutic use | Lymphoma, T-Cell, Cutaneous - drug therapy | Tetrahydronaphthalenes - adverse effects | Hyperlipidemias - prevention & control | Anticarcinogenic Agents - adverse effects | Hypolipidemic Agents - therapeutic use | Thyroxine - therapeutic use | Hypothyroidism - prevention & control | Hyperlipidemias - chemically induced | Anticarcinogenic Agents - therapeutic use | T cells | Complications and side effects | Lymphomas | Index Medicus
Book Review
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text ADMET considerations for restless leg syndrome drug treatments
by de Biase, Stefano and Merlino, Giovanni and Lorenzut, Simone and Valente, Mariarosaria and Gigli, Gian Luigi
Expert opinion on drug metabolism & toxicology, ISSN 1742-5255, 10/2012, Volume 8, Issue 10, pp. 1247 - 1261
toxicology | periodic leg movements | ropinirole | absorption | pramipexole | restless legs syndrome | rotigotine | augmentation | distribution | levodopa | iron | pregabalin | gabapentin enacarbil | metabolism | pharmacokinetic | dopamine | elimination | tolerance | Dopamine | Elimination | Tolerance | Iron | Pregabalin | Metabolism | Pharmacokinetic | Pramipexole | Augmentation | Restless legs syndrome | Ropinirole | Toxicology | Absorption | Distribution | Rotigotine | Levodopa | Periodic leg movements | Gabapentin enacarbil | Pharmacology & Pharmacy | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Thiophenes - therapeutic use | Thiophenes - adverse effects | Humans | Dopamine Agonists - therapeutic use | Levodopa - pharmacokinetics | Tetrahydronaphthalenes - therapeutic use | Dopamine Agonists - adverse effects | Ergolines - adverse effects | Dopamine Agents - therapeutic use | Tetrahydronaphthalenes - adverse effects | Benzothiazoles - pharmacokinetics | Carbamates - pharmacokinetics | Dopamine Agents - adverse effects | Ergolines - pharmacokinetics | Restless Legs Syndrome - drug therapy | Anticonvulsants - adverse effects | Dopamine Agents - pharmacokinetics | Amines - therapeutic use | Amines - adverse effects | gamma-Aminobutyric Acid - therapeutic use | Neuralgia - physiopathology | gamma-Aminobutyric Acid - adverse effects | gamma-Aminobutyric Acid - pharmacokinetics | Anticonvulsants - pharmacokinetics | Cyclohexanecarboxylic Acids - therapeutic use | Levodopa - therapeutic use | Cyclohexanecarboxylic Acids - adverse effects | Anticonvulsants - therapeutic use | Dopamine Agonists - pharmacokinetics | Tetrahydronaphthalenes - pharmacokinetics | Treatment Outcome | Neuralgia - drug therapy | Randomized Controlled Trials as Topic | Ergolines - therapeutic use | Thiophenes - pharmacokinetics | Indoles - adverse effects | Levodopa - adverse effects | Amines - pharmacokinetics | Carbamates - adverse effects | Indoles - pharmacokinetics | Indoles - therapeutic use | Benzothiazoles - therapeutic use | Cyclohexanecarboxylic Acids - pharmacokinetics | Carbamates - therapeutic use | gamma-Aminobutyric Acid - analogs & derivatives | Benzothiazoles - adverse effects | Index Medicus | Drugs | Intravenous administration | Nutrient deficiency | Clinical trials | Neuropathy | Leg | Quality of life | Anticonvulsants | Mood | Kidney diseases | Long-term effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights